Menu

About Us Industry Report Services Press Release Careers Contact Us

Consumer Genomics Market, by Application (Genetic Relatedness, Diagnostics, Lifestyle, Wellness, & Nutrition, Ancestry, Reproductive Health, Personalized Medicine & Pharmacogenetic Testing, Sports Nutrition & Health, Others): Global Opportunity Analysis and Industry Forecast, 2020-2027

LI20102151

Pages: 155

Feb 2023

The global consumer genomics market is estimated to surpass $6,427.8 million by 2027, exhibiting a CAGR of 20.5% from 2020 to 2027.

The report provides all-inclusive analysis of global consumer genomics market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.

The report emphasizes current market scenario and future trends of the global consumer genomics market which gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market. Besides, the report provides Porter’s five forces analysis which precisely underlines the impact of key forces on the global consumer genomics market.

In addition, the report provides market size and forecast scrutinizing global consumer genomics market through different segments. The report highlights the geographical market analysis of these segments and each segment is thoroughly studied at regional as well as country level to get clearer picture of the global consumer genomics market. In the report, the global consumer genomics market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover consumer genomics market landscape in respective regions.

Furthermore, competitive scenario of the global consumer genomics market is covered in the report. Major players functioning in the global consumer genomics market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global consumer genomics market, and others.

Research Methodology

Research Dive offers its clients extensive research and analysis gleaned from wide variety of factual inputs that largely includes interview with participants of the industry, reliable data & statistics, and regional intelligence. The in-house experts of the industry play a crucial role in designing analytic tools and models, tailor-made to the requests of an industry segment. The data and statistics are sterilized with these analytical tools and models, which enhances the accuracy of our advice and recommendations.

This research report is delivered by Research Dive by conducting long hours of discussions and interviews, with a broad range of stakeholders, which includes upstream and downstream participants. Our analysts have performed a mix of primary and secondary research for the market estimations and forecasts. A number of product type literatures, industry releases, annual reports, and other related documents of major participants of the industry have been reviewed, to better understand the global consumer genomics market scenario. The initial phase of our in-depth study, where we perform wide-range data mining, referring to proficient & verified data sources such as independent studies, medical journals, technical journals, releases by trade association, materials published by government & regulatory authorities, and other.

KEY MARKET BENEFITS

  • This report is a compilation of detailed study, information, valid inputs from industry experts & industry participants across the value chain, and quantitative & qualitative assessment by analysts of the industry.
  • The report provides a comprehensive analysis along with the current trends of market during the forecast period from 2019 to 2027 to identify & comprehend the prevailing opportunities and the strategic assessment of the global consumer genomics market growth.
  • The report studies the market from 2019 to 2027 and maps the qualitative impact of several industry factors on market segments as well as geographies.
  • The report provides market estimations and size which is based on in-depth analysis of recent & key developments in the consumer genomics market.
  • The development strategies implemented by the key industry players are conscripted in the report to understand the competitive scenario of the global consumer genomics market.

KEY MARKET SEGMENTS

The market has been studied based on the following segments:

  • Application: Genetic Relatedness, Diagnostics, Lifestyle, Wellness, & Nutrition, Ancestry, Reproductive Health, Personalized Medicine & Pharmacogenetic Testing, Sports Nutrition & Health, Others

Region:

The global consumer genomics market is divided into North America, Europe, Asia Pacific, and LAMEA.

The above-mentioned regions are further dived in countries as follows:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of LAMEA

 

KEY MARKET PLAYERS

The report covers the major players operating in the global consumer genomics market that focus on advancements & innovations and geographical expansion of product portfolios to obtain a competitive edge in the market space. The major players enlisted in the report include Gene By Gene, Ltd., Pathway Genomics, Ancestry, Diagnomics, Inc., …., and others.

The report summarizes various aspects of all these key players that include as follows:

    1. Ancestry

    2. 23andMe, Inc.

    3. Gene By Gene, Ltd.

    4. Mapmygenome

    5. Pathway Genomics

    6. Veritas

    7. Myriad Genetics, Inc.

    8. Illumina, Inc.

    9. Amgen, Inc.

    10. Diagnomics, Inc.

  • 1. RESEARCH METHODOLOGY

    • 1.1. Desk Research

    • 1.2. Real time insights and validation

    • 1.3. Forecast model

    • 1.4. Assumptions and forecast parameters

    • 1.5. Market size estimation

      • 1.5.1. Top-down approach

      • 1.5.2. Bottom-up approach

  • 2. REPORT SCOPE

    • 2.1. Market definition

    • 2.2. Key objectives of the study

    • 2.3. Report overview

    • 2.4. Market segmentation

    • 2.5. Overview of the impact of COVID-19 on Global Consumer Genomics Market

  • 3. EXECUTIVE SUMMARY

  • 4. MARKET OVERVIEW

    • 4.1. Introduction

    • 4.2. Growth impact forces

      • 4.2.1. Drivers

      • 4.2.2. Restraints

      • 4.2.3. Opportunities

    • 4.3. Market value chain analysis

      • 4.3.1. List of raw material suppliers

      • 4.3.2. List of manufacturers

      • 4.3.3. List of distributors

    • 4.4. Innovation & sustainability matrices

      • 4.4.1. Technology matrix

      • 4.4.2. Regulatory matrix

    • 4.5. Porter’s five forces analysis

      • 4.5.1. Bargaining power of suppliers

      • 4.5.2. Bargaining power of consumers

      • 4.5.3. Threat of substitutes

      • 4.5.4. Threat of new entrants

      • 4.5.5. Competitive rivalry intensity

    • 4.6. PESTLE analysis

      • 4.6.1. Political

      • 4.6.2. Economical

      • 4.6.3. Social

      • 4.6.4. Technological

      • 4.6.5. Environmental

    • 4.7. Impact of COVID-19 on Consumer Genomics Market

      • 4.7.1. Pre-covid market scenario

      • 4.7.2. Post-covid market scenario

  • 5. Consumer Genomics Market, By End Use

    • 5.1. Overview

    • 5.2 Genetic Relatedness

      • 5.2.1 Definition, key trends, growth factors, and opportunities

      • 5.2.2 Market size analysis, by region, 2020-2027

      • 5.2.3 Market share analysis, by country, 2020-2027

    • 5.3 Diagnostics

      • 5.3.1 Definition, key trends, growth factors, and opportunities

      • 5.3.2 Market size analysis, by region, 2020-2027

      • 5.3.3 Market share analysis, by country, 2020-2027

    • 5.4 Lifestyle, Wellness, & Nutrition

      • 5.4.1 Definition, key trends, growth factors, and opportunities

      • 5.4.2 Market size analysis, by region, 2020-2027

      • 5.4.3 Market share analysis, by country, 2020-2027

    • 5.5 Ancestry

      • 5.5.1 Definition, key trends, growth factors, and opportunities

      • 5.5.2 Market size analysis, by region, 2020-2027

      • 5.5.3 Market share analysis, by country, 2020-2027

    • 5.6 Reproductive Health

      • 5.6.1 Definition, key trends, growth factors, and opportunities

      • 5.6.2 Market size analysis, by region, 2020-2027

      • 5.6.3 Market share analysis, by country, 2020-2027

    • 5.7 Personalized Medicine & Pharmacogenetic Testing

      • 5.7.1 Definition, key trends, growth factors, and opportunities

      • 5.7.2 Market size analysis, by region, 2020-2027

      • 5.7.3 Market share analysis, by country, 2020-2027

    • 5.8 Sports Nutrition & Health

      • 5.8.1 Definition, key trends, growth factors, and opportunities

      • 5.8.2 Market size analysis, by region, 2020-2027

      • 5.8.3 Market share analysis, by country, 2020-2027

    • 5.9 Others

      • 5.9.1 Definition, key trends, growth factors, and opportunities

      • 5.9.2 Market size analysis, by region, 2020-2027

      • 5.9.3 Market share analysis, by country, 2020-2027

    • 5.10 Research Dive Exclusive Insights

      • 5.10.1 Market attractiveness

      • 5.10.2 Competition heatmap

  • 6. Consumer Genomics Market, By Region

    • 6.1 North America

      • 6.1.1 U.S

        • 6.1.1.1 Market size analysis, By End Use, 2020-2027

      • 6.1.2 Canada

        • 6.1.2.1 Market size analysis, By End Use, 2020-2027

      • 6.1.3 Mexico

        • 6.1.3.1 Market size analysis, By End Use, 2020-2027

      • 6.1.4 Research Dive Exclusive Insights

        • 6.1.4.1 Market attractiveness

        • 6.1.4.2 Competition heatmap

    • 6.2 Europe

      • 6.2.1 Germany

        • 6.2.1.1 Market size analysis, By End Use, 2020-2027

      • 6.2.2 UK

        • 6.2.2.1 Market size analysis, By End Use, 2020-2027

      • 6.2.3 France

        • 6.2.3.1 Market size analysis, By End Use, 2020-2027

      • 6.2.4 Spain

        • 6.2.4.1 Market size analysis, By End Use, 2020-2027

      • 6.2.5 Italy

        • 6.2.5.1 Market size analysis, By End Use, 2020-2027

      • 6.2.6 Rest of Europe

        • 6.2.6.1 Market size analysis, By End Use, 2020-2027

      • 6.2.7 Research Dive Exclusive Insights

        • 6.2.7.1 Market attractiveness

        • 6.2.7.2 Competition heatmap

    • 6.3 Asia-Pacific

      • 6.3.1 China

        • 6.3.1.1 Market size analysis, By End Use, 2020-2027

      • 6.3.2 Japan

        • 6.3.2.1 Market size analysis, By End Use, 2020-2027

      • 6.3.3 India

        • 6.3.3.1 Market size analysis, By End Use, 2020-2027

      • 6.3.4 Australia

        • 6.3.4.1 Market size analysis, By End Use, 2020-2027

      • 6.3.5 South Korea

        • 6.3.5.1 Market size analysis, By End Use, 2020-2027

      • 6.3.6 Rest of Asia-Pacific

        • 6.3.6.1 Market size analysis, By End Use, 2020-2027

      • 6.3.7 Research Dive Exclusive Insights

        • 6.3.7.1 Market attractiveness

        • 6.3.7.2 Competition heatmap

    • 6.4 LAMEA

      • 6.4.1 Brazil

        • 6.4.1.1 Market size analysis, By End Use, 2020-2027

      • 6.4.2 Saudi Arabia

        • 6.4.2.1 Market size analysis, By End Use, 2020-2027

      • 6.4.3 UAE

        • 6.4.3.1 Market size analysis, By End Use, 2020-2027

      • 6.4.4 South Africa

        • 6.4.4.1 Market size analysis, By End Use, 2020-2027

      • 6.4.5 Rest of LAMEA

        • 6.4.5.1 Market size analysis, By End Use, 2020-2027

      • 6.4.6 Research Dive Exclusive Insights

        • 6.4.6.1 Market attractiveness

        • 6.4.6.2 Competition heatmap

  • 7. Competitive Landscape

    • 7.1 Top winning strategies, 2020-2027

      • 7.1.1 By strategy

      • 7.1.2 By year

    • 7.2 Strategic overview

    • 7.3 Market share analysis, 2020-2027

  • 8. Company Profiles

    • 8.1 Ancestry

      • 8.1.1 Overview

      • 8.1.2 Business segments

      • 8.1.3 Product portfolio

      • 8.1.4 Financial performance

      • 8.1.5 Recent developments

      • 8.1.6 SWOT analysis

    • 8.2 23andMe, Inc.

      • 8.2.1 Overview

      • 8.2.2 Business segments

      • 8.2.3 Product portfolio

      • 8.2.4 Financial performance

      • 8.2.5 Recent developments

      • 8.2.6 SWOT analysis

    • 8.3 Gene By Gene, Ltd.

      • 8.3.1 Overview

      • 8.3.2 Business segments

      • 8.3.3 Product portfolio

      • 8.3.4 Financial performance

      • 8.3.5 Recent developments

      • 8.3.6 SWOT analysis

    • 8.4 Mapmygenome

      • 8.4.1 Overview

      • 8.4.2 Business segments

      • 8.4.3 Product portfolio

      • 8.4.4 Financial performance

      • 8.4.5 Recent developments

      • 8.4.6 SWOT analysis

    • 8.5 Pathway Genomics

      • 8.5.1 Overview

      • 8.5.2 Business segments

      • 8.5.3 Product portfolio

      • 8.5.4 Financial performance

      • 8.5.5 Recent developments

      • 8.5.6 SWOT analysis

    • 8.6 Veritas

      • 8.6.1 Overview

      • 8.6.2 Business segments

      • 8.6.3 Product portfolio

      • 8.6.4 Financial performance

      • 8.6.5 Recent developments

      • 8.6.6 SWOT analysis

    • 8.7 Myriad Genetics, Inc.

      • 8.7.1 Overview

      • 8.7.2 Business segments

      • 8.7.3 Product portfolio

      • 8.7.4 Financial performance

      • 8.7.5 Recent developments

      • 8.7.6 SWOT analysis

    • 8.8 Illumina, Inc.

      • 8.8.1 Overview

      • 8.8.2 Business segments

      • 8.8.3 Product portfolio

      • 8.8.4 Financial performance

      • 8.8.5 Recent developments

      • 8.8.6 SWOT analysis

    • 8.9 Amgen, Inc.

      • 8.9.1 Overview

      • 8.9.2 Business segments

      • 8.9.3 Product portfolio

      • 8.9.4 Financial performance

      • 8.9.5 Recent developments

      • 8.9.6 SWOT analysis

    • 8.10 Diagnomics, Inc.

      • 8.10.1 Overview

      • 8.10.2 Business segments

      • 8.10.3 Product portfolio

      • 8.10.4 Financial performance

      • 8.10.5 Recent developments

      • 8.10.6 SWOT analysis

Purchase Full Report of
Consumer Genomics Market

PURCHASE OPTIONS

  

* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Enquire To Buy

Need to add more ?

Request Customization

Customers Also Viewed